AC Immune S.A. (ACIU) vs Q32 Bio Inc. (QTTB)
A side-by-side comparison of AC Immune S.A. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACIU
AC Immune S.A.
$2.55HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT
QTTB
Q32 Bio Inc.
$8.20HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ACIU vs QTTB
growth of $100 · dividends reinvested · last 9yACIU -74.7% (-14.2%/yr)QTTB -97.5% (-33.7%/yr)ACIU compounded faster over this window
Log scale — wide-divergence pair
ACIU QTTB
ACIU vs QTTB: by the numbers
- •ACIU is the larger company ($260M vs $244M market cap).
- •QTTB is profitable (62.87% net margin) while ACIU runs a net loss (-249.94%).
- •QTTB grew revenue faster over the past five years (10.22% vs -23.70% CAGR).
Metrics side by side
Valuation
| Metric | ACIU | QTTB |
|---|---|---|
| P/E ratio | N/A | 2.94 |
| P/S ratio | 11.96 | 4.54 |
| P/B ratio | 5.96 | 2.30 |
| EV / EBITDA | N/A | 6.53 |
Profitability
| Metric | ACIU | QTTB |
|---|---|---|
| Gross margin | 100.00% | 99.84% |
| Operating margin | -1927.32% | 31.45% |
| Net margin | -249.94% | 62.87% |
| ROE | -124.67% | 31.90% |
| ROIC | -89.43% | 19.43% |
Growth (annualized)
| Metric | ACIU | QTTB |
|---|---|---|
| Revenue CAGR (5Y) | -23.70% | 10.22% |
| Total return CAGR (5Y) | -16.03% | -41.51% |
Frequently asked
- Which has grown faster, ACIU or QTTB?
- Over the past five years, QTTB grew revenue faster — ACIU at a -23.70% CAGR versus QTTB at 10.22%.
- Is ACIU or QTTB more profitable?
- QTTB runs the higher net margin — ACIU at -249.94% versus QTTB at 62.87%.
- How have ACIU and QTTB total returns compared?
- Over the past 5 years, ACIU delivered -16.03% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Q32 Bio P/E ratioAC Immune ROEQ32 Bio ROEAC Immune operating marginQ32 Bio operating marginAC Immune revenue growthQ32 Bio revenue growthAC Immune free cash flowQ32 Bio free cash flow
AC Immune & Q32 Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.